Here are Tuesday's biggest analyst calls: SpaceX, Nvidia, Apple, Figma, Shopify, First Solar, Ferrari & more
Here are Tuesday's biggest calls on Wall Street: Deutsche Bank upgrades First Solar to buy from hold Deutsche said shares...
Eli Lilly and Co
Here are the 3 big things we're watching in the stock market this week
We're entering the quiet before the earnings storm. The Independence Day-shortened trading week is behind us. So is the June...
Medicare will start covering obesity drugs for the first time. Here's what patients should know
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity...
Chip stocks rebound, and Goldman racks up a series of M&A wins
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time...
America can't get enough of protein. The dairy industry can't keep up
Whitebalance.space | E+ | Getty ImagesAmerica's "protein-maxxing" obsession is stressing the dairy industry.Whey protein concentrate, once considered a cheap byproduct...
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news conference in...
Estrogen patches are hard to find, and it may not be resolved any time soon
Woman applying estrogen patch during hormone therapy.Halfpoint Images | Moment | Getty ImagesEstrogen patches are in short supply as demand...
What this biotech's volatile stock price tells you about the weight loss market right now
Shares of Danish biotech Zealand Pharma recently plunged after detailed data on its weight loss drug survodutide showed far higher...
Drugmakers race to find a place in the next wave of obesity drugs
Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even...
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare...
Here are 3 forces that drove a whirlwind week for the stock market
An avalanche of selling on Friday crushed the stock market, a dramatic reversal from record highs earlier in the week....
No tech, no problem. Dow makes record and traders think these stocks can lead now
The flashiest group in the market took a step back Thursday as chip stocks dropped 1.5%, but U.S. stock market...
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
Jacob Van Naarden is busy. In addition to running Eli Lilly's oncology business, he's now responsible for finding the drugmaker's next...
Stocks making the biggest moves premarket: Ferrari, Lear, Intuitive Machines, Micron Technology and more
Check out some of the companies making headlines before the stock market's opening bell: Autozone — The automotive parts distributor...
Want to hop off the AI trade? Goldman says buy these stocks that have nothing to do with it
It may feel like the artificial intelligence trade is sucking all the oxygen out of the stock market these days,...
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
A Biogen facility in Cambridge, Massachusetts.Brian Snyder | ReutersBiogen plans to advance an experimental drug for Alzheimer's disease to late-stage...
Novo Nordisk stock jumps 6% after drugmaker hikes forcast as Wegovy pill sales smash forecasts
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark,...
Weight loss and hair loss: The growing hair treatment market from GLP-1s
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary...
Dow rallies 700 points, S&P 500 hits new high as strong Alphabet, Caterpillar earnings overshadow Iran worries: Live updates
Traders works on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York on...
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook by...
